Choosing a biologics supplier is one of the biggest calls a regenerative practice makes. The product touches your patients, your marketing, your staff, and your legal exposure. Most practices pick a supplier on price and a rep’s pitch. This checklist gives you nine questions to ask before the first order.
TLDR: A good biologics supplier can show you registration, listing, and a certificate of analysis for the lot. It can also tell you, in writing, what you may say about the product. A weak one hands you a brochure and a promise. Most of the gaps we see are not paperwork at all. They are the missing plan for marketing, selling, administering, and explaining the product. Read on for the nine questions, in order, and the mistakes that cost practices the most.
Important Note
This article is for educational purposes only and does not constitute legal, medical, or regulatory advice. Marketing strategies discussed should be reviewed by qualified legal counsel before implementation, particularly regarding FDA, FTC, and state-specific advertising regulations. Regen Portal is a marketing and consulting company, not a law firm.
When a clinic shows us what a supplier gave them, the certificate of analysis and the establishment registration are often missing. Listing and chain of custody are sometimes missing too. That is the paperwork side. It is the easier half to fix.
The harder half is what nobody put in the box. There is nothing on how to market the product or how to sell it. Nothing on how to administer it. Nothing on how to tell patients the practice now offers it. Both sides miss these gaps because neither side knows to ask.
This post fixes that. You get nine questions, the rule behind each one, and the answer that should satisfy you. Suppliers, read it as a preview of what your best accounts will ask next.
Why the Biologics Supplier Conversation Goes Wrong
It goes wrong because it starts with the wrong question. When a physician calls us about adding cells or tissue, the questions come in a fixed order. Is it legal in my state? Where can I get it? How much can I charge? The supplier shows up at question two. By then the practice is ready to buy.
So the rep gets a warm audience and an easy close. Reps routinely say things to clinic owners that are not FDA compliant. That is normal in this industry. We have watched that language travel from the pitch into the clinic’s own ads and patient materials, superlatives included.
The practice then owns those words. The supplier does not publish the clinic’s website. The clinic does. A biologics supplier checklist puts the hard questions before the close. The next section covers the rules those questions rest on.
The Rules That Sit Behind the Questions
Three rules cover most of what you need. First, firms that make human cells, tissues, and cellular and tissue-based products under section 361 must register with FDA. They must also list those products. The rule is 21 CFR Part 1271. The FDA’s tissue establishment registration page says they must register within 5 days of starting operation and update it each December.
Second, registration is public. Anyone can search the HCTERS public query by establishment name, product, status, or location. That page also carries a line every practice should memorize. Registration and listing do not mean the firm is in compliance. They do not mean FDA licensed or approved the product. They do not mean the product truly belongs under section 361.
Third, labels have rules of their own. Under 21 CFR 1271.370, the label must carry a distinct ID code and a description of the product type. It must carry an expiration date where one applies, plus required warnings. Storage temperature may appear on the label or with it. So may the name and address of the firm that released the product.
The pathway matters as much as the paperwork. If the product is not a true 361 product, it needs a different route, and the marketing rules change with it. Our post on 361 versus 351 products covers that split. Counsel decides where a specific product lands. With these three rules in hand, the nine questions almost write themselves.
The Nine Questions to Ask Every Biologics Supplier
Ask these in order, in writing, before the first purchase order. A serious biologics supplier will have most answers ready. A weak one gets vague by question four.
1. Registration I Can Verify
Ask for the registration and the listing. Then check both yourself. The HCTERS query takes a few minutes. If your biologics supplier is a distributor, ask which firm holds the registration and confirm that one. If the name on the box does not match the name in the database, stop and ask why.
2. A Certificate for the Lot
Ask for the certificate of analysis (COA) for the exact lot you will receive. Not a sample from last year. At minimum it should identify the product, speak to purity, and tie to the lot number on the label. Keep a copy with the lot record. If the supplier cannot produce one, that tells you something.
3. Chain of Custody and Storage
Ask how the product moved from the firm to your door, and at what temperature. Ask what the shipping record looks like and who signs it. Then ask what your practice must do on arrival: storage, handling, and shelf life. The label rule above says storage temperature may travel with the product. Ask where you will find it.
4. The Pathway, in Writing
Ask the biologics supplier to state, in writing, which pathway the product sits on and why. “It is a 361 product” is a start, not an answer. Ask what the intended use is and why it is minimally manipulated and homologous. Then hand that letter to counsel. The supplier’s opinion does not bind FDA or protect your practice.
5. What I May Say, in Writing
Ask for a written claims guide. It lists the sentences the supplier stands behind and the ones it will not. This question sorts suppliers fast. Most practices that add a service line were never trained on how to do it right. The ones that were trained still do not know how to market it or how to teach staff to answer questions about it. A supplier that hands you approved wording and banned wording has solved half of that.
If they hand you a brochure full of hype instead, you have learned something too. Our post on the “is this FDA approved” question shows how to answer the question your staff will hear most.
6. What Happens on a Recall
Ask how the supplier will reach you if a lot is recalled, and how fast. Ask who at your practice is on their contact list. FDA posts recalls, market withdrawals, and safety alerts in a searchable list you can subscribe to. Subscribe anyway. Then ask what the supplier expects you to do for patients who received the lot, and who writes that letter.
7. What Training Comes With It
Ask what training the supplier gives, to whom, and in what format. Training the doctor is the obvious piece. Ask about the rest: front desk scripts, consent language, storage steps, and the record you keep for each dose. If training is one visit from the rep, ask what happens when staff turn over.
8. How I Explain It to Patients and Staff
Ask for a plain-language note on what the product is and is not. Patients will ask your front desk. They will ask your doctor. If the supplier’s answer includes the word “approved,” go back to question five. The best suppliers give you a one-page note a new hire can read on day one. Counsel has already reviewed it.
9. Who Carries the Risk for Clinic Copy
Ask who answers when a supplier claim lands on your website and FDA reads it. Get the answer in writing. In our experience the practice holds the risk, because it published the page. Ask for indemnity terms and let counsel judge them. Our guide to what warning letters usually cite shows what those letters look like when they land.
The table below condenses the nine questions into what you ask for and where you check it. The terms were defined above, so the cells stay short.
| Question | Ask For | Where to Check |
|---|---|---|
| Registration and listing | Registration and product listing | HCTERS public query |
| Certificate of analysis | COA for the exact lot | Your lot record |
| Chain of custody | Shipping and temperature record | Your intake log |
| Pathway | Written pathway statement | Your counsel |
| Claims | Written approved and banned wording | Your counsel and marketing lead |
| Recall | Written notice process | FDA recall list, your contact sheet |
| Training | Training plan by role | Your operations lead |
| Explanation | One-page plain explainer | Your front desk |
| Exposure | Indemnity terms | Your counsel |
With the checklist in hand, the next step is knowing where practices slip when they use it.
Common Mistakes When Vetting a Biologics Supplier
The most common mistake is taking the rep’s word for the papers. The second is treating the papers as the whole job. Both leave the practice exposed until a patient, a state board, or a new hire asks a hard question.
The practice checks the registration once, at signing, and never again. Registration updates every December, and a lapsed supplier will not send a note. Put a yearly lookup on the calendar.
Next, the practice files the COA and never matches it to a lot. A COA that does not tie to the lot in the freezer proves nothing. Match it on arrival and keep it with the log.
Then there is the copy problem. The practice pastes the supplier’s product blurb onto a service page because it sounds polished. That is how the rep’s hype becomes the clinic’s claims. Run each line of supplier copy through the same review your own copy gets.
Finally, most practices skip the training question because the doctor feels sure. The doctor is one person. The front desk and the marketing lead are the ones who get asked “is this approved?” A general vendor evaluation checklist covers the business side of any vendor. The nine questions above cover what is specific to a biologics supplier. A short story shows how these mistakes stack.
Picture a Practice That Skipped the Checklist
Picture a pain practice in a mid-sized city that adds an injectable biologic. The rep was friendly, the price was fair, and the product came on time. The doctor took a half-day training. The practice launched the service line within a month.
Then the questions came. A patient asked the front desk if the product was FDA approved. The front desk said yes, because the rep had said “FDA registered” and nobody knew the difference. The marketing lead built a page from the supplier’s brochure, hype and all. No one had a COA on file for the lot in the freezer.
Nothing happened for a while. Then a competitor’s ad drew a state board’s attention, and the board looked at everyone in town. The practice spent months rebuilding pages, pulling records, and retraining staff. The supplier was helpful. But the supplier had not published the page.
Now picture the same practice with the nine questions answered before the first order. Same product, same rep, same launch. The difference is a folder: registration, listing, a COA per lot, a pathway statement, and a claims guide. A one-page note sits at the front desk. That practice is not lucky. It is prepared.
Frequently Asked Questions
What Does “FDA Registered” Mean for a Biologics Supplier?
It means the firm has registered with FDA and listed its products. That is what 21 CFR Part 1271 requires for 361 products. It does not mean FDA approved, licensed, or inspected the product. FDA’s own query page says so. Never use “FDA registered” in marketing as an approval claim.
How Do I Verify a Biologics Supplier’s Registration?
Use the FDA’s HCTERS public query. Search by firm name, product, or state. Confirm the status is current. If your supplier is a distributor, find the firm that makes the product and confirm that one. Save a screenshot with the date. Repeat the lookup each year.
What Should a Certificate of Analysis Include?
At minimum it should identify the product, speak to its purity, and match the lot number on the label. Ask for one per lot, not a generic sample. Keep it with your lot log so you can match product to paper on demand. Counsel can advise on anything beyond that.
Can a Supplier Tell Me What I May Say in My Marketing?
A supplier can give you a written claims guide, and a good one will. That guide is a starting point, not a shield. Your practice publishes the page, so your practice answers for it. Run supplier wording through your own review and counsel before it goes live. Words like “approved” or “proven” should stop you cold.
What Happens if My Biologics Supplier Has a Recall?
The supplier should contact you directly with the lot numbers and next steps. FDA also posts recalls, market withdrawals, and safety alerts in a public list you can subscribe to. Before you buy, ask how notice works and who at your practice is on the list. Plan the patient letter early with counsel.
Should I Ask a Biologics Supplier for Staff Training?
Yes. Training the doctor covers one person. Your front desk, intake staff, and marketing lead will all be asked about the product. Ask the supplier for scripts, a plain-language note, and storage and record steps. If the supplier does not provide those, build them before launch.
Who Is Liable if Supplier Copy Lands on My Website?
In practice, whoever published the page carries the risk, and that is usually the clinic. Ask the supplier for indemnity terms in writing and have counsel weigh them. Then treat each line of supplier copy as your own claim, because regulators generally will. This is the question suppliers least expect.
Key Takeaways
- Registration and listing are public, so check them yourself before you sign and every year after.
- Registration does not mean approval, and “FDA registered” is never an approval claim.
- Ask for a certificate of analysis per lot and match it to the product in your freezer.
- Get the pathway and the approved claims in writing, then hand both to counsel.
- The gaps that hurt most are the missing plans for marketing, selling, and explaining the product.
- Your practice publishes the page, so your practice owns the claim, whoever wrote it.
Your Next Step
Regen Portal works with the supply side as well as the clinics. We see both ends of this conversation. We help practices build the folder, the front desk answers, and the service page, so the biologics supplier choice holds up later. We help suppliers build the claims guide and the one-page note their best accounts will ask for. Our consulting work with practices starts with a free audit, and scope is set in discovery, never quoted off a page.
If you already have a supplier, bring us the folder and the page.
PS: Send us your supplier’s brochure and your service page and we will give you a free compliance audit of both.
Email: hello@regenportal.com
YouTube: Subscribe to the channel
About Regen Portal
Regen Portal is a marketing and consulting company built for the regenerative medicine industry. We handle practice consulting, marketing compliance, search engine optimization, content creation, social media management, paid advertising, website development, branding, and AI and ops consulting for clinics, manufacturers, distributors, and independent providers. For more on me and how we work, visit Regen Portal and contact us.
About the Author
Oscar Tellez is the founder of Regen Portal, a marketing and consulting company built for the regenerative medicine industry. He has been in this industry since 2015. He started in medical sales and has worked with PRP since 2016. He has reached hundreds of practices and over 200 doctors through sales, teaching and marketing. He holds a B.S. in Exercise Science and Health Promotion from Florida Atlantic University.
